Anti-Obesity Drug Approved by FDA Advisory Panel

The Takeaway

This week a Federal Drug Administration panel backed the approval of a weight loss drug called Qnexa. Strictly intended for use by clinically overweight people with BMIs over 27kg/m2, Qnexa is a combination of an already-existing weight loss drug and another drug not yet approved for weight loss. At present, many doctors use this particular combination of drugs to treat obese patients, but this approval would allow them not to go “off the label” with their prescriptions. Art Caplan is a bioethicist.   Dr. Louis Aronne is director of the Comprehensive Weight Loss Program at New York Presbyterian Weill Cornell Medical Center.

Kickstart The World’s fundraising drive!

The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.

Make a gift today to help us raise $67,000  by the end of the year and keep The World going strong. Every gift will get us one step closer to our goal!